Current status and unanswered questions on the use of Denosumab in giant cell tumor of bone

Gaston, C.L.; Grimer, R.J.; Parry, M.; Stacchiotti, S.; Tos, A.P.D.; Gelderblom, H.; ... ; Rutkowski, P. (2016)

Article / Letter to editor

• Giant cell tumor of bone
• Denosumab
• Safety
• Neoadjuvant
• Inoperable
• Surgery

• All authors: Gaston, C.L.; Grimer, R.J.; Parry, M.; Stacchiotti, S.; Tos, A.P.D.; Gelderblom, H.; Ferrari, S.; Baldi, G.G.; Jones, R.L.; Chawla, S.; Casali, P.; LeCesne, A.; Blay, J.Y.; Dijkstra, S.P.D.; Thomas, D.M.; Rutkowski, P.
• Date: 2016-09-14
• Journal: Clinical Sarcoma Research
• Volume: 6
• DOI: doi:10.1186/s13569-016-0056-0